亚洲社会药学 ›› 2022, Vol. 17 ›› Issue (1): 70-75.

• • 上一篇    下一篇

Development Status and Enlightenment of Precision Medicine in China

  

  • 出版日期:2022-03-17 发布日期:2022-03-18

Development Status and Enlightenment of Precision Medicine in China

  • Online:2022-03-17 Published:2022-03-18

摘要: Objective To analyze the development status of precision medicine in China and summarize the problems so as to put forward some countermeasures to promote its high-quality development. Methods Literature research and comparative research were used to study the development status of precision medicine in China from the perspectives of market environment, product research and development (R&D) and policy environment. Results and Conclusion There are some problems in the field of precision medicine in China, such as technical barriers, less investment in new drug R&D, and imperfect regulatory measures. Therefore, some solutions are put forward. First, enterprises should be encouraged to strengthen their cooperation with innovative R&D. Second, the compensation system of drug patent protection period must be established as soon as possible. Lastly, overseas experience should be learned with scientific supervision.

关键词: precision medicine, development status, market scale, PD-1/L1, innovative R&D

Abstract: Objective To analyze the development status of precision medicine in China and summarize the problems so as to put forward some countermeasures to promote its high-quality development. Methods Literature research and comparative research were used to study the development status of precision medicine in China from the perspectives of market environment, product research and development (R&D) and policy environment. Results and Conclusion There are some problems in the field of precision medicine in China, such as technical barriers, less investment in new drug R&D, and imperfect regulatory measures. Therefore, some solutions are put forward. First, enterprises should be encouraged to strengthen their cooperation with innovative R&D. Second, the compensation system of drug patent protection period must be established as soon as possible. Lastly, overseas experience should be learned with scientific supervision.

Key words: precision medicine, development status, market scale, PD-1/L1, innovative R&D